Lucid Diagnostics Provides Business Update and Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
Lucid Diagnostics Inc (LUCD) PT Lowered to $3.80 at Cantor Fitzgerald
November 14, 2023 2:31 PM ESTCantor Fitzgerald analyst Ross Osborn lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $3.80 (from $4.00) while maintaining a Overweight rating.
The analyst comments "
Investment Summary. We reiterate our Overweight rating while we moderate our 12-month price target to $3.80 from $4.00 on Lucid... More
